INTRODUCTION
T uberculosis and leprosy are chronic granulomatous diseases caused by intracellular gram-positive acid-fast Bacilli and the host specific cell-mediated immune (CMI) response play pivotal role in determining the spectrum of the disease. [1] The prevalence of both diseases is rather high in endemic areas. [2] Interestingly, only 5% of individuals infected with Mycobacterium tuberculosis and Mycobacterium leprae are predisposed to develop tuberculosis and leprosy, respectively. [3] The reported incidence of pulmonary tuberculosis among leprosy patients ranged between 2.5% and 13.4%. [4, 5] hematological investigations, chest skiagram and ultrasonography of abdomen were unremarkable. Smear and culture from ulcer were negative for M. tuberculosis, fungus, and leishmaniasis. Slit skin smear for acid-fast Bacilli was negative. Mantoux test was positive (15 mm induration). Serology for human immune deficiency virus was nonreactive. Fine needle aspiration cytology (FNAC) and lymphnode biopsy could not be done as her mother did not consent. Nerve conduction studies revealed motor and sensory neuropathy of the right ulnar and median nerve. Histopathological examination of biopsy taken from the margin of the ulcer showed cohesive epithelioid granulomas with few Langhans giant cells along with plasma cells and lymphocytes in the dermis [ Figure 4 ]. Tissue for DNA polymerase chain reaction (PCR) for M. tuberculosis protein was positive. Characteristic clinical morphology, nerve conduction studies, DNA PCR for M. tuberculosis, and histopathology corroborated in establishing the diagnosis of LV with neuritic leprosy and incomplete claw hand deformity. The plan of treatment includes multi-drug therapy consisting of streptomycin 0.5 g, rifampicin 300 mg, isoniazid 150 mg, pyrazinamide 375 mg, and daily for first 2 months. Rifampicin 300 mg, isoniazid 150 mg, and dapsone 50 mg daily for next 4 months. [6] 
DISCUSSION
The relation between tuberculosis and leprosy is enigmatic, date back to Roman period and Donoghue et al., have demonstrated the existence of coinfection of M. tuberculosis and M. Leprae in human archeological samples by PCR. [7] However, the occurrence of leprosy and tuberculosis coinfection was first reported by Relvich et al. in 1954 [8] and the relationship between them is perplexing. Nonetheless, Casanova et al., corroborated the coexistence on the basis of similarity in amino acid sequence of 65 kDa between M. leprae and M. tuberculosis as evidenced by conversion of lepromin and tuberculin test after injection of BCG vaccine. [9] On the contrary, coexistence could be coincidental as M. tuberculosis, and M. leprae evince specific cell-mediated immunity by affecting different CD4/CD8 subpopulations. It is known that interferon (IFN)-gamma/interleukin (IL)-12 axis is necessary for the effective Th-1 response and deficiency of IFN-gamma/IL-12 axis leads to genetic susceptibility to mycobacterial diseases. However, quantitative study of IFN-gamma and IL-12 could not be done in the index case which could have apparently established susceptibility to M. leprae and M. tuberculosis infection.
Few cases of coexistence of leprosy and cutaneous tuberculosis have been reported in the literature [ Table 1 ]. [10] [11] [12] [13] [14] [15] Moreover, the coexistence of LV with neuritic leprosy, localized to the same limb in the index case is notable. Interestingly, there is no association of cutaneous tuberculosis with neuritic leprosy among the cases reported so far, including ours. Obviously, coexistence is observed among patients not having good CMI against M. leprae. It has been hypothesized that impaired CMI in lepromatous leprosy favor advancement of more virulent M. tuberculosis leading to leprosy predating pulmonary tuberculosis. [7] However, it may not be appropriate to extrapolate this conjecture to the index case as there is reasonably good CMI in neuritic leprosy and tuberculosis is of cutaneous type (paucibacillary) (LV). Moreover, earlier investigators suggested the existence of antagonism between two infections; that is those individuals with immunity against one infection (leprosy) are less susceptible to other infection (pulmonary tuberculosis) than the general population due to cross-immunity. [16] CONCLUSION To conclude, in endemic areas like India, coinfection of tuberculosis with leprosy can be contained by effective BCG vaccination as substantiated in a study from Brazil where decrease in detection rate of leprosy was correlated with increase in BCG vaccination coverage. [17] Financial Support and Sponsorship Nil.
14. Rao GR, Sandhya S, Sridevi M, Amareswar A, Narayana BL;
Shantisri. Lupus vulgaris and borderline tuberculoid leprosy: [10] 1 10 M TVC BT Dixit et al., (1991) [13] 1 65 F SFD LL Pinto et al., (1991) [12] 1 36 F TVC BT Patki et al., (1990) [11] 1 35 F LV BL LV: Lupus vulgaris, SFD: Scrofuloderma, TVC: Tuberculosis verrucosa cutis, BT: Borderline tuberculoid leprosy, BL: Borderline lepromatous leprosy, LL: Lepromatous leprosy
